The findings, published May 26 in Otolaryngology-Head and Neck Surgery, found that recent omicron variants have smell and taste loss at only 6 percent to 7 percent of early-stage variants. Six variants were examined: alpha, delta, omicron K, omicron L, omicron C and omicron B.
“Our research has shown that incidents of COVID-related smell and taste loss have dramatically changed over the course of the pandemic, to the point now that smell loss is no longer a common symptom of infection,” lead author Evan Reiter, MD, medical director of Richmond, Va.-based VCU Health’s Smell and Taste Disorders Center, said in a July 14 hospital news release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
